DMK PharmaceuticalsDMKPQ
13F holders, Q4 2024 (December 31)1holders −1
0new positions
1sold out
$0.00avg. 13F price*
At the end of Q4 2024, 1 institutions reported holding DMK Pharmaceuticals Corp. (DMKPQ) in their 13F filings, down 1 from Q3 2024. 0 opened new positions and 1 sold out. The largest holder was Winch Advisory Services, LLC ($0).
- Company
- DMK Pharmaceuticals Corp.
- CUSIP
- 00547W307
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 14 shares sold, net −14 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Winch Advisory Services, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is DMKPQ's weight in each manager's 13F, not the share of DMK Pharmaceuticals Corp. the manager owns.